-
公开(公告)号:US07414063B2
公开(公告)日:2008-08-19
申请号:US10547969
申请日:2004-03-25
申请人: Rima Salim Al-Awar , David Anthony Barda , Albert Gerard Dee , Kenneth James Henry, Jr. , Sajan Joseph , Ho-Shen Lin , Jose Eduardo Lopez , Michael Enrico Richett , Carmen Somoza
发明人: Rima Salim Al-Awar , David Anthony Barda , Albert Gerard Dee , Kenneth James Henry, Jr. , Sajan Joseph , Ho-Shen Lin , Jose Eduardo Lopez , Michael Enrico Richett , Carmen Somoza
IPC分类号: C07D217/02 , A61K31/47
CPC分类号: C07D401/02 , C07D217/04 , C07D217/22 , C07D217/24 , C07D405/12 , C07D409/12 , C07D413/02 , C07D413/12
摘要: The present invention relates to compounds Formula (I): as inhibitors of AKT activity, which are useful for the treatment of susceptible neoplasms and viral infections.
摘要翻译: 本发明涉及式(I)化合物:作为AKT活性的抑制剂,其可用于治疗易感性肿瘤和病毒感染。
-
2.7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B) 失效
标题翻译: 作为akt(蛋白激酶B)的抑制剂的7-苯基 - 异喹啉-5-磺酰基氨基衍生物公开(公告)号:US07449477B2
公开(公告)日:2008-11-11
申请号:US10595798
申请日:2004-11-22
申请人: David Anthony Barda , Kenneth James Henry, Jr. , Jianping Huang , Sajan Joseph , Ho-Shen Lin , Michael Enrico Richett
发明人: David Anthony Barda , Kenneth James Henry, Jr. , Jianping Huang , Sajan Joseph , Ho-Shen Lin , Michael Enrico Richett
IPC分类号: C07D217/22 , C07D401/12 , A61K31/4725 , A61K31/472
CPC分类号: C04B35/632 , C07D217/02 , C07D217/22 , C07D401/12
摘要: The present invention relates to compounds Formula (I) as inhibitors of AKT activity, which are useful for the treatment of susceptible neoplasms and viral infections.
摘要翻译: 本发明涉及作为AKT活性抑制剂的式(I)化合物,其可用于治疗易感性肿瘤和病毒感染。
-
公开(公告)号:US20120184577A1
公开(公告)日:2012-07-19
申请号:US13347886
申请日:2012-01-11
IPC分类号: A61K31/4745 , A61P35/00 , C07D471/04
CPC分类号: A61K31/4745 , C07D471/04
摘要: The present invention provides an imidazo[4,5-c]quinolin-2-one compound, or a pharmaceutically acceptable salt thereof, that inhibits both PI3K and mTOR and, therefore, is useful in the treatment of cancer.
摘要翻译: 本发明提供抑制PI3K和mTOR两者的咪唑并[4,5-c]喹啉-2-酮化合物或其药学上可接受的盐,因此可用于治疗癌症。
-
公开(公告)号:US08440829B2
公开(公告)日:2013-05-14
申请号:US13347886
申请日:2012-01-11
IPC分类号: C07D471/04
CPC分类号: A61K31/4745 , C07D471/04
摘要: The present invention provides an imidazo[4,5-c]quinolin-2-one compound, or a pharmaceutically acceptable salt thereof, that inhibits both PI3K and mTOR and, therefore, is useful in the treatment of cancer.
摘要翻译: 本发明提供抑制PI3K和mTOR两者的咪唑并[4,5-c]喹啉-2-酮化合物或其药学上可接受的盐,因此可用于治疗癌症。
-
公开(公告)号:US20090227622A1
公开(公告)日:2009-09-10
申请号:US11816416
申请日:2006-02-23
申请人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander Mclean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Yip , Boyu Zhong
发明人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander Mclean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Yip , Boyu Zhong
IPC分类号: A61K31/437 , C07D471/04
CPC分类号: C07D471/04
摘要: The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds.
摘要翻译: 本发明提供了下式所示的VEGF-R2抑制剂的化合物:(I)和使用这些化合物的方法。
-
公开(公告)号:US07666879B2
公开(公告)日:2010-02-23
申请号:US11816416
申请日:2006-02-23
申请人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
发明人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
IPC分类号: A01N43/42 , A61K31/44 , C07D471/02 , C07D491/02 , C07D498/02 , C07D513/02 , C07D515/02 , C07D401/00
CPC分类号: C07D471/04
摘要: The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds.
摘要翻译: 本发明提供了下式所示的VEGF-R2抑制剂的化合物:(I)和使用这些化合物的方法。
-
-
-
-
-